مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

205
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

139
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6

Pages

  153-160

Abstract

 Background: Niosomes or Nonionic surfactant vesicles are nano vehicles utilized in drug delivery systems, especially in cancer therapy. In this study, these vesicles were applied as delivery system for Anticancer drug, Paclitaxel and then, its Anticancer activities was compared with free Paclitaxel on Human Acute Lymphoblastic Leukemia (ALL) cell line Nalm-6. Materialas and Methods: In this exprimental study, Paclitaxel loaded Niosome was prepared by thin film hydration method. The characterization tests included dynamic light scattering (DLS) and UV-Vis spectrophotometry were employed to evaluate the quality of the nanocarriers. Cytotoxicity of niosomal Paclitaxel Nanoparticles and free Paclitaxel on human Acute Lymphoblastic Leukemia cell line Nalm-6 after 24 hours were studied by MTT assay to determine cell viability. Results: Percent of encapsulation Paclitaxel prepared with sorbitane monostearate, cholesterol, and DSPEmPEG 2000 was 97. 21 %. In addition, the polydispersity index, mean size diameter, and zeta potentials of niosomal Paclitaxel Nanoparticles were found to be 0. 244 ± 0. 011, 106. 3 ± 1. 5 nm, and-26. 03 ± 1. 34; respectively. Paclitaxel released from nanoNiosome in 72 h was 19. 81 %. The results demonstrated that a 2. 5∼ fold reduction in Paclitaxel concentration was measured when the Paclitaxel administered in nanoNiosome compared to free Paclitaxel solution in human Acute Lymphoblastic Leukemia cell line Nalm-6. Conclusion: As a result, the nanoparticle-based formulation of Paclitaxel has high potential as an adjuvant therapy for clinical usage in human Acute Lymphoblastic Leukemia therapy.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Alemi, Ashraf, Farrokhifar, Majid, ZARE ZARDINI, HADI, & HAGHI KARAMALLAH, MOJTABA. (2018). A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 8(3), 153-160. SID. https://sid.ir/paper/320699/en

    Vancouver: Copy

    Alemi Ashraf, Farrokhifar Majid, ZARE ZARDINI HADI, HAGHI KARAMALLAH MOJTABA. A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2018;8(3):153-160. Available from: https://sid.ir/paper/320699/en

    IEEE: Copy

    Ashraf Alemi, Majid Farrokhifar, HADI ZARE ZARDINI, and MOJTABA HAGHI KARAMALLAH, “A Comparison between the Anticancer Activities of Free Paclitaxel and Paclitaxel-Loaded Niosome Nanoparticles on Human Acute Lymphoblastic Leukemia Cell Line Nalm-6,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 8, no. 3, pp. 153–160, 2018, [Online]. Available: https://sid.ir/paper/320699/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button